Capabilities
Our Digital Health group guides companies through the myriad considerations they encounter as the delivery of healthcare becomes increasingly digital.
As private equity investment in the Life Sciences and Healthcare industry continues to increase, our cohesive regulatory and transactional approach helps ensure success through each phase of investment.
We provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health, from start-ups to global corporations.
Our Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
We established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to changes in healthcare transparency laws.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
June 30, 2026
FDA Signals Greater Flexibility for Single-Trial Drug Approvals
June 24, 2026
CMS Proposes Rule to Govern the “Medicare Drug Price Negotiation Program”
June 22, 2026
Health Headlines – June 22, 2026
July 8, 2026
Sports and Project Development Partner Eric Andalman Joins King & Spalding in Denver
July 7, 2026
Complex Commercial Litigation Partner Meredith Pohl Joins King & Spalding in Washington, D.C.
June 25, 2026
Partners Saranya Raghavan and Brian Nisbet join the firm’s Business Litigation practice group in Chicago